Sinopharm’s China TCM buyout bid lapses without regulatory nods
CHINA National Pharmaceutical Group’s latest attempt to take China Traditional Chinese Medicine (TCM) Holdings private has fallen through as it ...
CHINA National Pharmaceutical Group’s latest attempt to take China Traditional Chinese Medicine (TCM) Holdings private has fallen through as it ...
BITCOIN climbed to the highest level in two weeks with Vice-President Kamala Harris pledging to support a regulatory framework for ...
THE Monetary Authority of Singapore’s (MAS) new review group has identified priority areas for two workstreams amid its ongoing review ...
THE Monetary Authority of Singapore’s (MAS) new review group has identified priority areas for two workstreams amid its ongoing review ...
AUDITOR PwC has lost its largest mainland China-listed client, Bank of China (BOC), to rival EY, adding to an exodus ...
CHINA’S exports of rare earth minerals rose 2.24 per cent in July from June, customs data showed on Wednesday (Aug ...
THE Monetary Authority of Singapore (MAS) has reprimanded registered fund manager RVP One and its chief executive for breaching the ...
While the proposed changes are unlikely to alter their capital management strategies, Reits will have more latitude to manage leverage ...
COINBASE Global shares soared this year, and the potential for the rally to forge ahead has pushed Citigroup to upgrade ...
Daniel Li assumed the role of chairman of PwC China and Asia-Pacific with effect from Jul 1PRICEWATERHOUSECOOPERS (PwC) has named ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.